SCHEMBL30900241

SCHEMBL30900241

CCCCCCCCC(CCCCCC)CC(=O)OCCCCCC(CCCCCOC(=O)CN(C)C(=O)CC(CCCCCC)CCCCCCCC)N(C)CCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.31
▸ LTA4H P09960 1/20 0.31
▸ PRSS1 P07477 1/20 0.31
▸ PRSS2 P07478 1/20 0.31
▸ PRSS3 P35030 1/20 0.31
▸ MMP2 P08253 1/20 0.31
▸ MMP9 P14780 1/20 0.31
▸ MMP12 P39900 1/20 0.31
▸ TSHR P16473 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ PPARG P37231 1/20 0.30
▸ TLR4 O00206 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30900139 0.96 LTA4H (0.33) FAAHLTA4HPRSS1PRSS2PRSS3
SCHEMBL30900185 0.92 LTA4H (0.32) LTA4HMMP2MMP9MMP12
SCHEMBL30900238 0.92 LTA4H (0.32) LTA4HMMP2MMP9MMP12
SCHEMBL30900176 0.92 PPARG (0.34) LTA4HPPARG
SCHEMBL30900174 0.90 LTA4H (0.32) FAAHLTA4H
SCHEMBL30900232 0.89 MMP2 (0.32) FAAHLTA4HPRSS1PRSS2PRSS3
SCHEMBL30900209 0.87 TLR2 (0.32) FAAHPRSS1PRSS2PRSS3MMP2
SCHEMBL30900214 0.87 TLR2 (0.32) FAAHPRSS1PRSS2PRSS3MMP2
SCHEMBL30900193 0.86 TLR2 (0.33) FAAHPRSS1PRSS2PRSS3MMP2
SCHEMBL30900225 0.85 MMP2 (0.32) LTA4HMMP2MMP9MMP12TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594293-A1 AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS Nanovation Therapeutics Inc. (CA) 2025-08-06 — — EP disclosed
WO-2024065043-A1 AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS NANOVATION THERAPEUTICS INC. (CA) 2024-04-04 — — WO disclosed
Send feedback